MANGALAM DRUGS & ORGANICS LTD. - 532637 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on August 02, 2021 for Aditya Dhoot Mangalam Drugs & Organics Ltd - 532637 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on August 02, 2021 for Aditya Dhoot Mangalam Drugs & Organics Ltd - 532637 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on August 02, 2021 for Ajay Dhoot Mangalam Drugs & Organics Ltd - 532637 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 23, 2021 for Shree Rasbihari Trading and Investments Pvt Ltd Mangalam Drugs & Organics Ltd - 532637 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 23, 2021 for Shree Kishoriju Trading and Investments Pvt Ltd Mangalam Drugs & Organics Ltd - 532637 - Shareholding for the Period Ended June 30, 2021
Mangalam Drugs & Organics Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2021. For more details, kindly Click here MANGALAM DRUGS & ORGANICS LTD. - 532637 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
In terms of Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, as amended from time to time please find attached herewith the Compliance Certificate as received from "Link Intime India Private Limited" Registrar and Share Transfer Agent of the Company for the quarter ended June 30, 2021. Mangalam Drugs & Organics Ltd - 532637 - Statement Of Investor Complaints For The Quarter Ended June 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Geeta KariraDesignation :- Company Secretary and Compliance Officer Mangalam Drugs & Organics Ltd - 532637 - Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s
Pursuant to Regulation 30 read with part A of Schedule III of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 (the Listing Regulations) we wish to inform that the Board of Directors of the Company at its meeting held today i.e., July 6, 2021 inter-alia considered & approved appointment of M/s. V.S. Somani & Co., Chartered Accountants (Firm Registration No: - 117589W) as Statutory Auditors of the Company w.e.f. July 6, 2021 to fill up the casual vacancy caused due to resignation of M/s. Batliboi & Purohit, Chartered Accountants (Firm Registration No: - 101048W), and they shall hold office until the conclusion of the ensuing annual general meeting. Mangalam Drugs & Organics Ltd - 532637 - Outcome Of Board Meeting Held On Tuesday, July 6, 2021
Outcome of Board Meeting held on Tuesday, July 6, 2021